Clinical trials
Bronchiolitis Obliterans Syndrome trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 10 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
| Completed | 14 |
| Unknown status | 11 |
| Active, not recruiting | 6 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Sanofi | 3 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 3 |
| Ausper Biopharma Co., Ltd. | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| First Affiliated Hospital of Zhejiang University | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
| Shanghai Jiao Tong University School of Medicine | 2 |
| Wenzhou Medical University | 2 |
| Beijing Ditan Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiolitis Obliterans Syndrome | 51 |
| Graft vs Host Disease | 5 |
| Hepatitis B | 5 |
| Uremia | 5 |
| Leukemia | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Lymphoma, Follicular | 3 |
| Hematologic Neoplasms | 2 |
| Hepatitis B, Chronic | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
Trials
Showing 76 to 51 of 51. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.